TIVC Quote, Financials, Valuation and Earnings

VolitionRX has a net margin of -2145.71% compared to Tivic Health Systems's net margin of -2201.34%. Tivic Health Systems's return on equity of -192.41% beat VolitionRX's return on equity of --.

Tivic Health Systems has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX has an analysts' consensus of $2.94 which suggests that it could grow by 320%. Given that VolitionRX has higher upside potential than Tivic Health Systems, analysts believe VolitionRX is more attractive than Tivic Health Systems.

Tivic Health Systems has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VolitionRX has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.798%.

Tivic Health Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tivic Health Systems pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

Tivic Health Systems quarterly revenues are $70K, which are smaller than VolitionRX quarterly revenues of $246.4K. Tivic Health Systems's net income of -$1.5M is higher than VolitionRX's net income of -$5.4M. Notably, Tivic Health Systems's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tivic Health Systems is 3.35x versus 48.25x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -2145.71% compared to Tivic Health Systems's net margin of -2828.67%. Tivic Health Systems's return on equity of -192.41% beat Catheter Precision's return on equity of -137.84%.

Tivic Health Systems has a consensus price target of --, signalling downside risk potential of --. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 788.89%. Given that Catheter Precision has higher upside potential than Tivic Health Systems, analysts believe Catheter Precision is more attractive than Tivic Health Systems.

Tivic Health Systems has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.724, suggesting its less volatile than the S&P 500 by 172.434%.

Tivic Health Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tivic Health Systems pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

Tivic Health Systems quarterly revenues are $70K, which are smaller than Catheter Precision quarterly revenues of $143K. Tivic Health Systems's net income of -$1.5M is higher than Catheter Precision's net income of -$4M. Notably, Tivic Health Systems's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tivic Health Systems is 3.35x versus 2.58x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Vycor Medical has a net margin of -2145.71% compared to Tivic Health Systems's net margin of -8.84%. Tivic Health Systems's return on equity of -192.41% beat Vycor Medical's return on equity of --.

Tivic Health Systems has a consensus price target of --, signalling downside risk potential of --. On the other hand Vycor Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Tivic Health Systems has higher upside potential than Vycor Medical, analysts believe Tivic Health Systems is more attractive than Vycor Medical.

Tivic Health Systems has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Vycor Medical has a beta of -0.416, suggesting its less volatile than the S&P 500 by 141.563%.

Tivic Health Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vycor Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tivic Health Systems pays -- of its earnings as a dividend. Vycor Medical pays out -- of its earnings as a dividend.

Tivic Health Systems quarterly revenues are $70K, which are smaller than Vycor Medical quarterly revenues of $436.4K. Tivic Health Systems's net income of -$1.5M is lower than Vycor Medical's net income of -$38.6K. Notably, Tivic Health Systems's price-to-earnings ratio is -- while Vycor Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tivic Health Systems is 3.35x versus 2.53x for Vycor Medical. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -2145.71% compared to Tivic Health Systems's net margin of 0.18%. Tivic Health Systems's return on equity of -192.41% beat Xtant Medical Holdings's return on equity of -26.62%.

Tivic Health Systems has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 201.72%. Given that Xtant Medical Holdings has higher upside potential than Tivic Health Systems, analysts believe Xtant Medical Holdings is more attractive than Tivic Health Systems.

Tivic Health Systems has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.139, suggesting its less volatile than the S&P 500 by 113.918%.

Tivic Health Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tivic Health Systems pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Tivic Health Systems quarterly revenues are $70K, which are smaller than Xtant Medical Holdings quarterly revenues of $32.9M. Tivic Health Systems's net income of -$1.5M is lower than Xtant Medical Holdings's net income of $58K. Notably, Tivic Health Systems's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tivic Health Systems is 3.35x versus 0.65x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.